Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nonalcoholic fatty liver disease stratification by liver lipidomics
Olga Vvedenskaya, Tim Rose, Oskar Knittelfelder, et al.
Journal of Lipid Research (2021) Vol. 62, pp. 100104-100104
Open Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

The roles of dietary lipids and lipidomics in gut-brain axis in type 2 diabetes mellitus
Duygu Ağagündüz, Mehmet Arif İçer, Özge Yeşildemir, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 47
Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease
Aidan McGlinchey, Olivier Govaere, Dawei Geng, et al.
JHEP Reports (2022) Vol. 4, Iss. 5, pp. 100477-100477
Open Access | Times Cited: 64
Guiding the choice of informatics software and tools for lipidomics research applications
Zhixu Ni, Michele Wölk, Geoff Jukes, et al.
Nature Methods (2022) Vol. 20, Iss. 2, pp. 193-204
Open Access | Times Cited: 45
Lipid network and moiety analysis for revealing enzymatic dysregulation and mechanistic alterations from lipidomics data
Tim Rose, Nikolai Köhler, Lisa Falk, et al.
Briefings in Bioinformatics (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 30
Non-alcoholic fatty liver disease is characterised by a reduced polyunsaturated fatty acid transport via free fatty acids and high-density lipoproteins (HDL)
Gabriele Mocciaro, Michael Allison, Benjamin Jenkins, et al.
Molecular Metabolism (2023) Vol. 73, pp. 101728-101728
Open Access | Times Cited: 28
Clinical lipidomics in the era of the big data
Aleš Kvasnička, Lukáš Najdekr, Dana Dobešová, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2023) Vol. 61, Iss. 4, pp. 587-598
Open Access | Times Cited: 17
A new mechanism of thyroid hormone receptor β agonists ameliorating nonalcoholic steatohepatitis by inhibiting intestinal lipid absorption via remodeling bile acid profiles
Kai Sun, Nan-Lin Zhu, Suling Huang, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 10, pp. 2134-2148
Closed Access | Times Cited: 5
Clinical lipidomics – A community-driven roadmap to translate research into clinical applications
Olga Vvedenskaya, Michal Holčapek, Michael Vogeser, et al.
Journal of Mass Spectrometry and Advances in the Clinical Lab (2022) Vol. 24, pp. 1-4
Open Access | Times Cited: 23
Glucosylceramide in bunyavirus particles is essential for virus binding to host cells
Zina M. Uckeley, Maëva Duboeuf, Yu Gu, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 4
Integration of network pharmacology, lipidomics, and transcriptomics analysis to reveal the mechanisms underlying the amelioration of AKT-induced nonalcoholic fatty liver disease by total flavonoids in vine tea
Siyu Du, Xin Chen, Rumeng Ren, et al.
Food & Function (2024) Vol. 15, Iss. 9, pp. 5158-5174
Closed Access | Times Cited: 4
Metabolic effects of phospholipids extracted from capelin (Mallotus villosus) roe on HepG2 cells
Mingyu Yin, Guihong Luo, Ryosuke Matsuoka, et al.
Food Bioscience (2024) Vol. 59, pp. 104257-104257
Closed Access | Times Cited: 4
Transcriptome signatures of the lipid metabolism in the liver and partial characterisation of the plasma phospholipidome of a long-distance migratory bird, the Northern Wheatear (Oenanthe oenanthe)
Roberto Carlos Frias-Soler, Natalie A. Wellbrock, Laura Bîndilă, et al.
Comparative Biochemistry and Physiology Part D Genomics and Proteomics (2025) Vol. 55, pp. 101452-101452
Closed Access
Bioactive signalling lipids as drivers of chronic liver diseases
Eleanna Kaffe, Annamaria Tisi, Christiana Magkrioti, et al.
Journal of Hepatology (2023) Vol. 80, Iss. 1, pp. 140-154
Open Access | Times Cited: 12
Lipidomics—Paving the Road towards Better Insight and Precision Medicine in Rare Metabolic Diseases
Martina Zandl‐Lang, Barbara Plecko, Harald Köfeler
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1709-1709
Open Access | Times Cited: 11
Melatonin alleviates PM2.5‐induced glucose metabolism disorder and lipidome alteration by regulating endoplasmic reticulum stress
Zhou Du, Junjie Hu, Lisen Lin, et al.
Journal of Pineal Research (2022) Vol. 73, Iss. 4
Closed Access | Times Cited: 16
Enhancing Hepatic MBOAT7 Expression in Mice With Nonalcoholic Steatohepatitis
Martin C. Sharpe, Kelly D. Pyles, Taylor Hallcox, et al.
Gastro Hep Advances (2023) Vol. 2, Iss. 4, pp. 558-572
Open Access | Times Cited: 10
Liver-specific mitochondrial amidoxime–reducing component 1 (Mtarc1) knockdown protects the liver from diet-induced MASH in multiple mouse models
Yuanjun Guo, Zhengyu Gao, Edward L. LaGory, et al.
Hepatology Communications (2024) Vol. 8, Iss. 5
Open Access | Times Cited: 3
Dihydrosphingolipids are associated with steatosis and increased fibrosis damage in non-alcoholic fatty liver disease
Bohdan Babiy, Bruno Ramos‐Molina, L. Ocaña, et al.
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2023) Vol. 1868, Iss. 7, pp. 159318-159318
Closed Access | Times Cited: 8
A lipidomic study: Nobiletin ameliorates hepatic steatosis through regulation of lipid alternation
Xushan Yang, Linye Sun, Dongliang Feng, et al.
The Journal of Nutritional Biochemistry (2023) Vol. 118, pp. 109353-109353
Closed Access | Times Cited: 8
miR-32-5p induces hepatic steatosis and hyperlipidemia by triggering de novo lipogenesis
Ya‐Di Wang, Liang-Liang Wu, Yun-Ni Mai, et al.
Metabolism (2023) Vol. 146, pp. 155660-155660
Closed Access | Times Cited: 8
Obesity promotes fumonisin B1 hepatotoxicity
Léonie Dopavogui, Marion Régnier, Arnaud Polizzi, et al.
The Science of The Total Environment (2023) Vol. 891, pp. 164436-164436
Open Access | Times Cited: 7
Liver tissue lipids in metabolic dysfunction-associated steatotic liver disease with diabetes and obesity
Achuthan Sourianarayanane, Christopher R. Brydges, Arthur J. McCullough
Clinics and Research in Hepatology and Gastroenterology (2024) Vol. 48, Iss. 7, pp. 102402-102402
Closed Access | Times Cited: 2
Spatial lipidomics reveals zone-specific hepatic lipid alteration and remodeling in Metabolic dysfunction-associated steatohepatitis
Patcharamon Seubnooch, Matteo Montani, Jean‐François Dufour, et al.
Journal of Lipid Research (2024) Vol. 65, Iss. 9, pp. 100599-100599
Open Access | Times Cited: 2
Lipidomics analysis reveals new insights into the goose fatty liver formation
Rongxue Wei, Rong Ning, Chunchun Han, et al.
Poultry Science (2022) Vol. 102, Iss. 3, pp. 102428-102428
Open Access | Times Cited: 11
LC/MS-Based Untargeted Metabolomics Study in Women with Nonalcoholic Steatohepatitis Associated with Morbid Obesity
Laia Bertran, Jordi Capellades, Sònia Abelló, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 9789-9789
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top